Welcome to the "Potter Clarkson’s events at Medicon Village" page!

Discover upcoming events, meet our team, gain valuable insights, and book your complimentary introductory IP clinic session.

Upcoming events

PATENTING INVENTIONS IN THE CLINICAL PHASE

This session will look at the considerations for IP and patent strategy for companies with products in the pre-clinical and clinical phases. We will cover reasons to develop an IP strategy extending beyond just “products per se”, how to spot inventions in the pre-clinical and clinical phases, and our tips and tricks for success.

Key takeaways will include:

  • Why patenting inventions in the pre-clinical and clinical phases of development is important for your commercial strategy.
  • How you can spot and protect inventions during this period (both using patents and other forms of IP).
  • How to present your IP strategy to maximise investment opportunities during this phase.

Sign up here

ANTIBODIES AND CELL THERAPIES UNLEASHED

  • Date: Wednesday 28 May 2025, 12:00 (BST) / 13:00 (CET)
  • Location: Online
  • Speakers: Tom Harding and Kevin Rich

Are broad antibody claims a thing of the past? Must you include the CDRs, or can you direct claims to an epitope? Does the same apply to related molecules like Chimeric Antigen Receptors?

One way to find out more is to join us for this exciting webinar on sticky immunology.

Sign up here

THE ROLE OF R&D IN YOUR PATENTING PROCESS AND VICE VERSA

This session looks in detail at patents and the patenting process, including spotting potentially patentable inventions and generating enough supporting data. Potter Clarkson will also discuss the relevance of third-party patents and common patenting mistakes. This session is particularly relevant to those working in R&D functions.

Key takeaways will include:

  • Recognising novel and patentable aspects within research outputs
  • The role of R&D professionals in supporting the patenting process, including when collaborating with third parties
  • Typical mistakes in R&D patent strategy and how to prevent them

Sign up here

DROP-IN IP CLINIC

This 30-minute meeting will give you the opportunity to discuss how to create an IP and legal strategy to maximise the commercial value of your intellectual property. Our experts give helpful general advice about the issues that are relevant to your business.

Sign up here

Latest Events

Combination therapies: IP considerations for synergistic biologic products

Combination therapies: IP considerations for synergistic biologic products

Perfect storm – four drivers behind the mRNA litigation wave

Perfect storm – four drivers behind the mRNA litigation wave

Patent landscape and freedom-to-operate analysis for RNA-based therapies: identifying IP risks early

Patent landscape and freedom-to-operate analysis for RNA-based therapies: identifying IP risks early

Kodak v FujiFilm: the Court of Appeal confirms UPC’s long-arm jurisdiction

Kodak v FujiFilm: the Court of Appeal confirms UPC’s long-arm jurisdiction

Comparing EPC Article 53(a) and US patent law in gene editing ethics

Comparing EPC Article 53(a) and US patent law in gene editing ethics

EPO Board of Appeal refers claim interpretation and added matter questions

EPO Board of Appeal refers claim interpretation and added matter questions

Creating an effective IP strategy for CAR-T

Creating an effective IP strategy for CAR-T

When is a synbio company a gene therapy company?

When is a synbio company a gene therapy company?

See All News